Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
iVAST: Intra-arterial Vasospasm Trial
NCT01996436Phase 4Terminated
- Start
- Aug 2016
- Primary completion
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of nicardipine, verapamil and nitroglycerin in cerebral vasospasm (3 arms). Primary endpoint: Post Infusion Improvement Ratio. Started Aug 2016; status: terminated.
02
Drugs
nicardipineverapamilnitroglycerin
03
Conditions
cerebral vasospasm
Beyond the preview
Go deeper on NCT01996436.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01996436.